Second-quarter earnings season is just around the corner and it's probably not going to turn any heads. Here's a preview of what to expect More
-
Sponsored By:
-
Sponsored By:
-
Sponsored By:
NVO
Recent Articles
New Obesity Drug Could Launch in U.S. Before 2015
Danish drug-maker Novo Nordisk says its anti-obesity treatment liraglutide could become available for sale in the U.S. by the end of 2014. More
AAPL Is Still Sour; Look for New Opportunities
The markets are in the middle of a strong rally, and a resurgent Apple is helping to lead the way. I still think it's a stock to sell. More
3 Call Contenders in Pharmaceuticals
These pharmaceutical stocks are doing something right--all have shown up as strong buys on my Power Stock scanner. More
6 Call Contenders Releasing Earnings
These bullish stocks are all reporting this week -- why not take advantage with call options? More
Get Ready For the Next Dividend Rush
A dividend rush is on as companies begin to go ex-dividend. Here is a list to follow on companies with dividend payments coming up More
4 Pharma Stocks to Sell
Sell these four bitter pills before they make your profits sicken. More
